18 FDG PET/CT Prediction of Treatment Outcomes in Patients with P16-Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer (LAOPC) Receiving Deintensified Therapy: Results from NRG-HN002.